Boardroom Breaches: Factory Dispute Exposes AI Venture Governance Risks

The hyper-competitive race to fund and build artificial intelligence startups has collided head-on with corporate governance norms. A public dispute between Factory, an AI-assisted software development startup, and its former venture board adviser, Chris Degnan, has laid bare the mounting structural conflicts within venture capital portfolios. Degnan, a partner at Sutter Hill Ventures, recently joined rival AI engineering startup Cognition as its chief revenue officer, prompting Factory's leadership to publicly accuse him of leveraging his advisory position to gather intelligence for a competitor.

This conflict represents a broader, systemic challenge for the venture capital industry. As top-tier firms aggressively back multiple overlapping players in the generative AI space, the traditional lines of fiduciary duty and information firewalls are being pushed to their limits. For years, founders accepted board observers and informal advisers from their lead investment firms as a standard cost of capital. Today, with billions of dollars flowing into direct competitors often separated by only a few months of development, those close relationships are transforming into liabilities.

For institutional limited partners, these public governance breakdowns are a growing source of anxiety. When venture partners transition directly into executive roles at competing portfolio companies, it threatens both the reputation of the fund and the proprietary IP of the early-stage startups they back. The fallout from the Factory and Cognition dispute suggests that the industry's self-policing norms are no longer sufficient to manage the intense commercial pressures of the AI market.

As a result, the dynamics of cap table assembly are shifting. Founders are beginning to negotiate much tighter information-sharing agreements and explicit non-compete covenants for board observers and venture advisers. In an environment where speed-to-market is the primary moat, securing capital can no longer come at the expense of operational security. Investors who cannot guarantee strict firewalls within their portfolios may find themselves locked out of the most competitive deals.